India — Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans

India received 504 FDA import refusals in Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans between 2024-Q1 and 2026-Q4. Volume peaked at 93 in 2026-Q3, with the trend roughly flat year-on-year. The most-cited issues are unapproved new drug, establishment not listed, and false or misleading label. No trade baseline is published for this commodity from India, so no per-$1B rate is shown here.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

One email a week, and only when something matches. We'll send a confirmation link first; unsubscribe any time from the footer of any email.

Key figures

If you import vitamins, minerals, proteins, and unconventional dietary specialties for humans from India

Hazard or paperwork: Of 519 refusals in the last 3 years, 68 were hazard findings and 451 paperwork alone — most were avoidable at the desk.
Where refusals happen: DSEI — Southeast (433); DNEI — Northeast (59); DNBI — North Border, the Canadian land border (12).
Riskiest months: July, September, August, by refusals since 2020.
Test for before shipping: unsafe color additive (22), Salmonella (17), unsafe food additive (9), poisonous or deleterious substance (6), filth (4).
Paperwork to get right: unapproved new drug (398), nutrition labeling (49), establishment not listed (48).

FDA does not publish how many entries it examines, so no page can state a true probability of refusal; these are the figures that are published.

Quarterly refusals, last 12 quarters

hazard findings labelling & registration

Show the numbers

Quarter	Refusals	Hazard	Paperwork
2024-Q1	23	5	18
2024-Q2	25	6	19
2024-Q3	32	2	30
2024-Q4	34	3	31
2025-Q1	46	5	41
2025-Q2	54	8	46
2025-Q3	41	5	36
2025-Q4	50	7	43
2026-Q1	52	6	46
2026-Q2	35	6	29
2026-Q3	93	11	82
2026-Q4	19	1	18

By commodity, last 156 weeks

Commodity	Refusals	1 refusal per	Per $1B US imports	Most-cited hazard
Supplements	327	—	—	unapproved new drug
Herbals-Botanicals	192	—	—	unapproved new drug

"1 refusal per X t": tonnes of the same product imported for every one, over the same 156 weeks. A dash means fewer than 5 in the window, or under 1,000 t a year imported, too few to rate; the total row pools every product that has import tonnes on record.

Recent refusals

EJG-2602155-6 2026-10-22 VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. Import division DNBI. false or misleading label
1FX-5649391-0 2026-10-21 ASHWAGANDHA (HERBAL & BOTANICALS, NOT TEAS) Import division DSEI. unapproved new drug
AEK-2058257-2 2026-10-21 VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. Import division DSEI. unapproved new drug
AEK-2027330-5 2026-10-21 VITAMIN, N.E.C. Import division DSEI. unapproved new drug
1FX-8631279-1 2026-10-21 CALCIUM (MINERAL) Import division DSEI. establishment not listedunapproved new drug
FY4-0124128-3 2026-10-21 MORINGA OLEIFERA (HERBAL AND BOTANICAL TEAS II, (CONTINUED) Import division DNEI. Salmonella
AEK-9852396-0 2026-10-21 HERBALS & BOTANICALS (NOT TEAS), N.E.C. Import division DSEI. unapproved new drug
1FX-9342133-8 2026-10-20 HERBALS & BOTANICALS (NOT TEAS), N.E.C. Import division DSEI. unapproved new drug
1FX-7691795-5 2026-10-19 ASHWAGANDHA (HERBAL & BOTANICALS, NOT TEAS) Import division DSEI. unapproved new drug
1FX-3489737-2 2026-10-08 VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. Import division DSEI. unapproved new drug
AEK-9603625-4 2026-10-08 ASHWAGANDHA (HERBAL & BOTANICALS, NOT TEAS) Import division DSEI. unapproved new drug
1FX-1129280-3 2026-10-08 COCCULUS Import division DSEI. unapproved new drug
1FX-3876690-4 2026-10-08 PROBIOTICS (VIT/MIN/PROTEIN/UNCONVENTIONAL DIETARY SPEC FOR HUMAN/ANIMAL, N.E.C.) Import division DSEI. unapproved new drug
KM6-3685330-1 2026-10-07 HERBALS & BOTANICALS (NOT TEAS), N.E.C. Import division DNEI. unapproved new drug
1FX-6668149-6 2026-10-06 HERBALS & BOTANICALS (NOT TEAS), N.E.C. Import division DSEI. establishment not listedunapproved new drug
AEK-0710428-3 2026-10-02 FOLIC ACID (VITAMIN) Import division DSEI. unapproved new drug
1FX-0754914-1 2026-10-02 ZINC (MINERAL) Import division DSEI. unapproved new drug
1FX-5943542-1 2026-10-02 HERBALS & BOTANICAL TEAS, N.E.C. Import division DSEI. unapproved new drug
AEK-9616633-3 2026-10-02 VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. Import division DSEI. unapproved new drug
1FX-4836945-9 2026-09-30 VITAMIN, N.E.C. Import division DSEI. unapproved new drug

Data and downloads

Download all 809 entries (CSV) — every refusal behind this page, with its import division, FDA product code, charges and whether it was a hazard finding or paperwork.

The file holds entries up to 2026-10-22. To get new ones for India by email, watch India.

India country report since 2020 — every refusal by year, charge and import division →